7733.T
7733.T
JP3201200007
OLYMPUS CORPORATION
Loading chart...

Company Profile

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Related stocks

4543.T
4543.T • Japan
TERUMO CORP
2,284 JPY
21.29B USD 1Y -8.9%
688271.SS
688271.SS • China
SHANGHAI UNITED IMAGING HEALTHC
107.78 CNY
13.29B USD 1Y -31.6%
6869.T
6869.T • Japan
SYSMEX CORP
1,855 JPY
7.09B USD 1Y -0.7%
300760.SZ
300760.SZ • China
MR
161.4 CNY
29.27B USD 1Y -35%
COH.AX
COH.AX • Australia
COCHLEAR FPO [COH]
128.39 AUD
5.87B USD 1Y -54.5%
688114.SS
688114.SS • China
MGI TECH CO LTD
67.95 CNY
4.23B USD 1Y -4.7%
6849.T
6849.T • Japan
NIHON KOHDEN CORP
1,643 JPY
1.66B USD 1Y -11.6%
002223.SZ
002223.SZ • China
YUYUE MEDICAL
26.12 CNY
3.89B USD 1Y -33%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
35.9% p.a.
Max Drawdown (5Y)
-58.8%
Sharpe Ratio (5Y)
-0.16
Beta Factor
0.26
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -58.8% in the extended horizon.
ende